Stratton Management’s Quest Diagnostics DGX Stock Holding History

Stratton Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$640K	Hold	8,998	–	–	0.08%	166
2015 Q3	$553K	Buy	8,998 +1,000	+13%	+$69.9K	0.06%	177
2015 Q2	$580K	Sell	7,998 -600	-7%	-$44.3K	0.03%	270
2015 Q1	$661K	Sell	8,598 -1,148	-12%	-$82.2K	0.03%	277
2014 Q4	$654K	Buy	9,746 +2,198	+29%	+$139K	0.03%	274
2014 Q3	$458K	Sell	7,548 -2,348	-24%	-$145K	0.02%	282
2014 Q2	$581K	Sell	9,896 -52	-0.5%	-$3.04K	0.02%	277
2014 Q1	$576K	Sell	9,948 -50	-0.5%	-$2.68K	0.03%	275
2013 Q4	$535K	Sell	9,998 -200	-2%	-$11.9K	0.03%	285
2013 Q3	$630K	Sell	10,198 -1,600	-14%	-$95.8K	0.03%	276
2013 Q2	$715K	Buy	+11,798	New	+$703K	0.04%	255

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Stratton Management's DGX Position: Q4 2015 in Review

Stratton Management held its Quest Diagnostics (DGX) position steady in Q4 2015 at 8,998 shares worth $640K. The position accounts for 0.08% of the portfolio, ranked #166.

Stratton Management first reported a position in DGX in Q2 2013 and has held it in 11 quarters since. The position peaked at $715K in Q2 2013. 535 funds tracked by Wall St. Rank hold DGX as of Q4 2015.

Stratton Management held 8,998 shares of Quest Diagnostics worth $640K as of Q4 2015.
Stratton Management left its Quest Diagnostics share count unchanged in Q4 2015.
Quest Diagnostics made up 0.08% of Stratton Management's portfolio in Q4 2015, its #166 holding.
Stratton Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 11 quarters since.
Stratton Management's Quest Diagnostics position peaked at $715K in Q2 2013.
535 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.